1188 related articles for article (PubMed ID: 26210792)
1. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
[TBL] [Abstract][Full Text] [Related]
2. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
3. Left atrial fibrosis correlates with extent of left ventricular myocardial delayed enhancement and left ventricular strain in hypertrophic cardiomyopathy.
Latif SR; Nguyen VQ; Peters DC; Soufer A; Henry ML; Grunseich K; Testani J; Hur DJ; Huber S; Mojibian H; Dicks D; Sinusas AJ; Meadows JL; Papoutsidakis N; Jacoby D; Baldassarre LA
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1309-1318. PubMed ID: 30790116
[TBL] [Abstract][Full Text] [Related]
4. Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.
Ellims AH; Iles LM; Ling LH; Hare JL; Kaye DM; Taylor AJ
J Cardiovasc Magn Reson; 2012 Oct; 14(1):76. PubMed ID: 23107451
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
6. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
7. Left Atrial Performance in the Course of Hypertrophic Cardiomyopathy: Relation to Left Ventricular Hypertrophy and Fibrosis.
Kowallick JT; Silva Vieira M; Kutty S; Lotz J; Hasenfu G; Chiribiri A; Schuster A
Invest Radiol; 2017 Mar; 52(3):177-185. PubMed ID: 27741021
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of global myocardial mechanics in hypertrophic cardiomyopathy by cardiovascular magnetic resonance feature tracking. Relations to left ventricular hypertrophy and fibrosis.
Hinojar R; Fernández-Golfín C; González-Gómez A; Rincón LM; Plaza-Martin M; Casas E; García-Martín A; Fernandez-Mendez MA; Esteban A; Nacher JJJ; Zamorano JL
Int J Cardiol; 2017 Dec; 249():467-472. PubMed ID: 29121751
[TBL] [Abstract][Full Text] [Related]
9. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
10. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
[TBL] [Abstract][Full Text] [Related]
11. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular function in patients with hypertrophic cardiomyopathy and its relation to myocardial fibrosis and exercise tolerance.
Maragiannis D; Alvarez PA; Ghosn MG; Chin K; Hinojosa JJ; Buergler JM; Shah DJ; Nagueh SF
Int J Cardiovasc Imaging; 2018 Jan; 34(1):121-129. PubMed ID: 28748418
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular short-axis systolic function changes in patients with hypertrophic cardiomyopathy detected by two-dimensional speckle tracking imaging.
Huang J; Yan ZN; Rui YF; Fan L; Liu C; Li J
BMC Cardiovasc Disord; 2018 Jan; 18(1):13. PubMed ID: 29378516
[TBL] [Abstract][Full Text] [Related]
14. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific differences of left ventricular rotational mechanics between cardiac amyloidosis and hypertrophic cardiomyopathy.
Nucifora G; Muser D; Morocutti G; Piccoli G; Zanuttini D; Gianfagna P; Proclemer A
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H680-8. PubMed ID: 24993044
[TBL] [Abstract][Full Text] [Related]
17. Effects of hypertrophy and fibrosis on regional and global functional heterogeneity in hypertrophic cardiomyopathy.
Chang SA; Lee SC; Choe YH; Hahn HJ; Jang SY; Park SJ; Choi JO; Park SW; Oh JK
Int J Cardiovasc Imaging; 2012 Dec; 28 Suppl 2():133-40. PubMed ID: 23097128
[TBL] [Abstract][Full Text] [Related]
18. Extent of late gadolinium enhancement at right ventricular insertion points in patients with hypertrophic cardiomyopathy: relation with diastolic dysfunction.
Zhu Y; Park EA; Lee W; Kim HK; Chu A; Chung JW; Park JH
Eur Radiol; 2015 Apr; 25(4):1190-200. PubMed ID: 25597022
[TBL] [Abstract][Full Text] [Related]
19. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
[TBL] [Abstract][Full Text] [Related]
20. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
